Tourki Bochra, Halade Ganesh
Laboratoire des Venins et Biomolécules Thérapeutiques et Plateforme de Physiologie et de Physiopathologie Cardiovasculaires, Institut Pasteur de Tunis, Université Carthage Tunis, Carthage, Tunisia.
Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA
FASEB J. 2017 Oct;31(10):4226-4239. doi: 10.1096/fj.201700109R. Epub 2017 Jun 22.
In response to myocardial infarction (MI), time-dependent leukocyte infiltration is critical to program the acute inflammatory response. Post-MI leukocyte density, residence time in the infarcted area, and exit from the infarcted injury predict resolving or nonresolving inflammation. Overactive or unresolved inflammation is the primary determinant in heart failure pathology post-MI. Here, our review describes supporting evidence that the acute inflammatory response also guides the generation of healing and regenerative mediators after cardiac damage. Time-dependent leukocyte density and diversity and the magnitude of myocardial injury is responsible for the resolving and nonresolving pathway in myocardial healing. Post MI, the diversity of leukocytes, such as neutrophils, macrophages, and lymphocytes, has been explored that regulate the clearance of deceased cardiomyocytes by using the classic and reparative pathways. Among the innovative factors and intermediates that have been recognized as essential in acute the self-healing and clearance mechanism, we highlight specialized proresolving mediators as the emerging factor for post-MI reparative mechanisms-translational leukocyte modifiers, such as aging, the source of leukocytes, and the milieu around the leukocytes. In the clinical setting, it is possible that leukocyte diversity is more prominent as a result of risk factors, such as obesity, diabetes, and hypertension. Pharmacologic agents are critical modifiers of leukocyte diversity in healing mechanisms that may impair or stimulate the clearance mechanism. Future research is needed, with a focused approach to understand the molecular targets, cellular effectors, and receptors. A clear understanding of resolving and nonresolving inflammation in myocardial healing will help to develop novel targets with major emphasis on the resolution of inflammation in heart failure pathology.-Tourki, B., Halade, G. Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
针对心肌梗死(MI),时间依赖性白细胞浸润对于启动急性炎症反应至关重要。心肌梗死后白细胞密度、在梗死区域的停留时间以及从梗死损伤部位的离开情况可预测炎症的消退或持续。过度活跃或未消退的炎症是心肌梗死后心力衰竭病理过程的主要决定因素。在此,我们的综述描述了支持性证据,即急性炎症反应也指导心脏损伤后愈合和再生介质的产生。时间依赖性白细胞密度和多样性以及心肌损伤的程度决定了心肌愈合中的消退和持续途径。心肌梗死后,已对中性粒细胞、巨噬细胞和淋巴细胞等白细胞的多样性进行了探索,这些白细胞通过经典途径和修复途径调节死亡心肌细胞的清除。在已被认为对急性自我修复和清除机制至关重要的创新因素和中间体中,我们强调专门的促消退介质是心肌梗死后修复机制的新兴因素——转化白细胞调节剂,如衰老、白细胞来源以及白细胞周围的环境。在临床环境中,由于肥胖、糖尿病和高血压等危险因素,白细胞多样性可能更为突出。药物制剂是愈合机制中白细胞多样性的关键调节剂,可能会损害或刺激清除机制。未来需要进行有针对性的研究,以了解分子靶点、细胞效应器和受体。清楚了解心肌愈合中炎症的消退和持续情况将有助于开发新的靶点,主要侧重于解决心力衰竭病理中的炎症问题。——图尔基,B.,哈拉德,G. 心脏重塑消退和持续机制中的白细胞多样性